NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces the completion of the sale of its Avenova eyecare business and related assets to PRN Physician Recommended Nutriceuticals, LLC (“PRN”) for $11.5 million (the “Asset Sale”). The Asset Sale, representing substantially all of the assets of the Company, was consummated pursuant to the Asset Purchase Agreement dated September 19, 2024, as amended, which NovaBay stockholders approved at the Special Meeting of Stockholders (“Special Meeting”) reconvened on January 16, 2025.
Read the full article: NovaBay Pharmaceuticals Completes the Sale of Its Eyecare Business to PRN //
Source: https://www.businesswire.com/news/home/20250123539123/en/NovaBay-Pharmaceuticals-Completes-the-Sale-of-its-Eyecare-Business-to-PRN-and-Further-Adjourns-its-Special-Meeting-of-Stockholders-on-Dissolution-Proposal